#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15720	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2196	712.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1411	1411	C	947	C	877	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15720	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2196	712.6	0	HET	.	.	.	A69G	.	69	69	A	296	296	A	918	A,G	656,187	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28488	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3501	810.8	0	.	n	.	0	T695C	SNP	695	695	T	947	947	C	885	C	826	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28488	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3501	810.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1589	1589	A	990	A	924	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28488	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3501	810.8	0	.	n	.	0	C1346T	SNP	1346	1346	C	1598	1598	T	989	T,C	912,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28488	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3501	810.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2223	2223	C	973	C,T	886,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28488	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3501	810.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2297	2297	A	920	A	852	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28488	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3501	810.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2849	2849	C	922	C	855	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	12	blaTEM	861	323	99.69	blaTEM.l15.c30.ctg.1	323	2.2	0	.	p	.	0	V101G	NONSYN	301	303	GTT	81	83	GGT	3;3;3	G;G,T;T	2;0,2;2	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2284	folP	855	855	100.0	folP.l15.c17.ctg.1	1445	157.3	1	SNP	p	R229S	1	.	.	685	687	AGC	961	963	AGC	219;220;222	A;G;C	202;206;207	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6378	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3295	192.9	1	SNP	p	S91F	1	.	.	271	273	TTC	496	498	TTC	190;191;190	T;T,C;C	177;176,1;176	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6378	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3295	192.9	1	SNP	p	D95G	1	.	.	283	285	GGC	508	510	GGC	195;195;196	G;G,A;C	178;177,1;180	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6378	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3295	192.9	1	SNP	p	G95N	0	.	.	283	285	GGC	508	510	GGC	195;195;196	G;G,A;C	178;177,1;180	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1832	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1253	145.3	1	SNP	p	G45D	0	.	.	133	135	GGC	518	520	GGC	245;245;247	G;G;C	221;218;222	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	844	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1043	80.6	0	.	n	.	0	A197.	DEL	197	197	A	577	577	A	208	A	185	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5606	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2970	188.4	1	SNP	p	D86N	0	.	.	256	258	GAC	590	592	GAC	236;233;233	G;A;C	216;210;215	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5606	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2970	188.4	1	SNP	p	R87I	0	.	.	259	261	CGT	593	595	CGT	235;235;234	C;G;T	215;218;218	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5606	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2970	188.4	1	SNP	p	S87R	1	.	.	259	261	CGT	593	595	CGT	235;235;234	C;G;T	215;218;218	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5606	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2970	188.4	1	SNP	p	R87W	0	.	.	259	261	CGT	593	595	CGT	235;235;234	C;G;T	215;218;218	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5606	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2970	188.4	1	SNP	p	S88P	0	.	.	262	264	TCC	596	598	TCC	236;235;240	T;C;C,A	220;219;217,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4992	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2597	191.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1529	1531	GGC	245;245;243	G;G;C	221;218;215	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2482	167.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1269	1271	GCA	235;235;240	G;C,A;A	205;206,1;212	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2482	167.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1272	1274	ATC	240;241;242	A;T;C	211;212;212	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2482	167.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1284	1286	GTG	249;244;245	G;T;G	224;217;222	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2482	167.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1284	1286	GTG	249;244;245	G;T;G	224;217;222	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2482	167.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1788	1790	ACC	216;215;215	A;C;C	193;196;197	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2482	167.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1842	1844	GCG	177;177;178	G;C,G;G	164;149,1;157	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2482	167.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1842	1844	GCG	177;177;178	G;C,G;G	164;149,1;157	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2482	167.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1965	1967	AGC	203;201;200	A;G;C	190;187;187	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2482	167.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1974	1976	GGC	197;196;198	G;G,A;C,T	184;183,1;181,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2482	167.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1992	1994	CCG	165;170;164	C,CA;C;G	106,1;116;111	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6262	ponA	2397	2397	100.0	ponA.l6.c17.ctg.1	3052	204.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1571	1573	CCG	228;231;233	C;C;G	200;210;200	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2702	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1869	144.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	564	564	C	170	C	159	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2798	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1503	184.7	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	591	593	AAG	221;220;218	A;A;G	201;201;199	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2798	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1503	184.7	0	.	p	.	0	E212D	NONSYN	634	636	GAA	867	869	GAT	238;240;240	G,A;A,C,G;T	219,1;220,1,1;222	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2798	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1503	184.7	0	.	p	.	0	H213G	NONSYN	637	639	CAT	870	872	GGT	240;241;239	G,A;G,A;T	219,1;221,2;217	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2798	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1503	184.7	0	.	p	.	0	V215A	NONSYN	643	645	GTT	876	878	GCT	236;233;236	G,T;C,T;T	217,1;214,1;219	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2798	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1503	184.7	0	.	p	.	0	I218M	NONSYN	652	654	ATC	885	887	ATG	234;229;230	A,G;T;G,C	217,1;213;212,2	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2798	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1503	184.7	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1002	1004	ACG	242;241;243	A;C;G	226;225;224	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2798	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1503	184.7	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1008	1010	GTT	249;250;248	G;T;T	230;230;228	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2798	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1503	184.7	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1122	1124	AAC	231;231;233	A,G;A;C	210,1;214;213	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2798	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1503	184.7	1	SNP	p	D121N	0	.	.	361	363	GAC	594	596	GAC	216;215;214	G;A;C,T	199;198;196,1	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2798	porB1b	1047	1047	98.76	porB1b.l6.c4.ctg.1	1503	184.7	1	SNP	p	A121D	1	.	.	361	363	GAC	594	596	GAC	216;215;214	G;A;C,T	199;198;196,1	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10364	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4722	218.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1068	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	990	107.3	1	SNP	p	V57M	1	.	.	169	171	ATG	555	557	ATG	226;228;226	A;TG,T;G	211;214,1;210	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
